HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In Vitro and In Silico Determination of Some N-ferrocenylmethylaniline Derivatives as Anti-Proliferative Agents Against MCF-7 Human Breast Cancer Cell Lines.

AbstractBACKGROUND:
Since the binding of estradiol to its receptor promotes breast cancer cell proliferation (in the ER+ tumours), many molecules targeting this protein have been synthesized to counteract the estradiol action. Ferrocene derivatives have proved their efficiency against hormone-dependent breast cancer cells (MCF-7).
OBJECTIVE:
In this study, we aimed to find new ferrocene derivatives having pharmacochemistry properties as potential drugs against human breast cancer cells.
METHODS:
A series of 29 N-ferrocenylmethylaniline derivatives A0-A28 were synthesised, and their anti-proliferative activity against both hormone-dependent (MCF-7) and independent (MDA-MB 231) human breast cancer cell lines were performed using the MTT test. Molecular docking and drug-likeness prediction were also performed for the five most active derivatives towards MCF-7. A QSAR model was also developed for the perdition of the anti-proliferative activity against MCF-7 cell lines using molecular descriptors and MLR analysis.
RESULTS:
All studied derivatives demonstrated better cytotoxicity against MCF-7 compared to the MDA-MB-231 cell lines, and compounds A2, A9, A14, A17 and A27 were the most potent ones but still less active than the standard anticancer drug, crizotinib. The QSAR study revealed good predictive ability, as shown by R2 cv = 0.848.
CONCLUSION:
In vitro and in silico results indicated that derivatives A2, A9, A14, A17, and A27 possess the highest anti-proliferative activity; these results can be used to design more potent N-ferrocenylmethylaniline derivatives as anti-proliferative agents.
AuthorsNadjiba Zegheb, Cherifa Boubekri, Touhami Lanez, Elhafnaoui Lanez, Tuba Tüylü Küçükkılınç, Esin Öz, Ali Khennoufa, Saida Khamouli, Salah Belaidi
JournalAnti-cancer agents in medicinal chemistry (Anticancer Agents Med Chem) Vol. 22 Issue 7 Pg. 1426-1437 ( 2022) ISSN: 1875-5992 [Electronic] Netherlands
PMID34170810 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright© Bentham Science Publishers; For any queries, please email at [email protected].
Chemical References
  • Antineoplastic Agents
  • Metallocenes
  • Estradiol
Topics
  • Antineoplastic Agents (chemistry)
  • Breast Neoplasms (drug therapy, pathology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Estradiol (pharmacology)
  • Female
  • Humans
  • MCF-7 Cells
  • Metallocenes (pharmacology)
  • Molecular Docking Simulation
  • Molecular Structure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: